Because of the different injury model in assessing the role of CX3CR1 in ischemic injury between our study and those of others, the conflicting findings suggest that the protection afforded by this chemokine in temporary occlusion (focal ischemia) may be more profound compared to permanent occlusion (global ischemia). This evidence concerns the gene CX3CR1 and ischemia.